Cargando…

Current role of systematic biopsy in diagnosis of clinically significant prostate cancer in primary combined MRI-targeted biopsy: a high-volume single-center study

PURPOSE: Additive systematic biopsy (SB) contributes to prostate cancer (PCA) detection in MRI-targeted biopsy (TB). However, the reasons for this are not yet clear. We compared the performance of TB, SB and the combined approach (CB) in biopsy-naive men to determine the added value of SB for tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krausewitz, Philipp, Fostitsch, Dorothea, Weiten, Richard, Kluemper, Niklas, Stein, Johannes, Luetkens, Julian, Kristiansen, Glen, Ellinger, Jörg, Ritter, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849165/ https://www.ncbi.nlm.nih.gov/pubmed/36477403 http://dx.doi.org/10.1007/s00345-022-04230-w

Ejemplares similares

Early Dynamics of Quantitative SEPT9 and SHOX2 Methylation in Circulating Cell-Free Plasma DNA during Prostate Biopsy for Prostate Cancer Diagnosis
por: Krausewitz, Philipp, et al.
Publicado: (2022)

Prospective analysis of pain expectancy and experience during MR-fusion prostate biopsy: does reality match patients’ expectancy?
por: Krausewitz, Philipp, et al.
Publicado: (2022)

DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men—study protocol for a randomized trial
por: Krausewitz, P., et al.
Publicado: (2023)

Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers
por: von Danwitz, Marthe, et al.
Publicado: (2023)

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
por: Zhang, Kai, et al.
Publicado: (2020)

The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy
por: Syring, Isabella, et al.
Publicado: (2018)

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers
por: Klümper, Niklas, et al.
Publicado: (2020)

MRI - ultrasound fusion guided biopsy of the prostate: lesion volume as a predictor of cancer in patients with repeat biopsies
por: Blaine, Scott Alan, et al.
Publicado: (2019)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Inflammatory fibroid polyp of the renal pelvis: first report at an extra-gastrointestinal site with molecular confirmation
por: Nagy, Dora, et al.
Publicado: (2023)

Fungaemia caused by obstructive renal candida bezoars leads to bilateral chorioretinitis: a case report
por: Stein, Johannes, et al.
Publicado: (2018)

Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma
por: Frey, Lisa, et al.
Publicado: (2021)

The role of MRI/TRUS fusion biopsy in the diagnosis of clinically significant prostate cancer
por: Benelli, Andrea, et al.
Publicado: (2020)

Bleeding management in computed tomography-guided liver biopsies by biopsy tract plugging with gelatin sponge slurry
por: Handke, Nikolaus A., et al.
Publicado: (2021)

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
por: Cheng, Xueqing, et al.
Publicado: (2021)

Does experience change the role of systematic biopsy during MRI-fusion biopsy of the prostate?
por: Jahnen, Matthias, et al.
Publicado: (2023)

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men
por: Peltier, Alexandre, et al.
Publicado: (2015)

Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy
por: Yashi, Masahiro, et al.
Publicado: (2014)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
por: Vėželis, Alvydas, et al.
Publicado: (2021)

In-bore MRI targeted biopsy
por: Gurgitano, Martina, et al.
Publicado: (2020)

Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning
por: Lee, Alvin Y. M., et al.
Publicado: (2022)

Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
por: Krüger-Stokke, Brage, et al.
Publicado: (2021)

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
por: Leow, Jeffrey J, et al.
Publicado: (2022)

A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsies
por: Derigs, Fabian, et al.
Publicado: (2021)

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)

Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution
por: Okubo, Yoichiro, et al.
Publicado: (2022)

Correction: Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning
por: Lee, Alvin Y. M., et al.
Publicado: (2022)

Optimal PSA Threshold for Obtaining MRI-Fusion Biopsy in Biopsy-Naïve Patients
por: Wang, Luke L., et al.
Publicado: (2021)

The Clinical Value of Performing an MRI before Prostate Biopsy
por: Choi, Myung Sun, et al.
Publicado: (2011)

MRI-targeted prostate biopsy: the next step forward!
por: Cata, Emanuel Darius, et al.
Publicado: (2021)

Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer
por: Venderink, Wulphert, et al.
Publicado: (2017)

Systematic expression analysis of m(6)A RNA methyltransferases in clear cell renal cell carcinoma
por: Gundert, Larissa, et al.
Publicado: (2021)

MRI-fusion biopsy: the contemporary experience
por: Bjurlin, Marc A., et al.
Publicado: (2017)

Diagnostic significance of biopsies in renal masses
por: Dogan, Bayram, et al.
Publicado: (2014)

The Significance of Liquid Biopsy in Pancreatic Cancer
por: Qi, Zi-Hao, et al.
Publicado: (2018)

Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer
por: Stinnesbeck, Melissa, et al.
Publicado: (2021)

Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
Publicado: (2015)

Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy
por: Nelson, Adam W., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bct4bnuth5mhsgql2ql62asl9d